NDC 66658-230 – Synagis
Palivizumab 50 mg/.5mL · Injection, Solution · Intramuscular
Product NDC66658-230
Product details
- Brand name
- Synagis
- Generic name
- Palivizumab
- Labeler
- Swedish Orphan Biovitrum AB (publ)
- Dosage form
- Injection, Solution
- Route
- Intramuscular
- Marketing category
- BLA · BLA103770
- Marketed since
- December 9, 1999
- Marketing end
- September 30, 2026
- Pharmacologic class
- Respiratory Syncytial Virus Anti-F Protein Monoclonal Antibody
Active ingredients
- Palivizumab 50 mg/.5mL
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 66658-230-01 | .5 mL in 1 VIAL, SINGLE-DOSE (66658-230-01) | Sep 28, 2005 |